UPDATE: Opko Announces Received Patent from US PTO for Rayaldee, Says On Schedule for NDA Filing During Q1'15
July 22, 2014 at 10:53 AM EDT
OPKO Health, Inc. (NYSE: OPK), a multinational biopharmaceutical and diagnostics company, today announced that the United States Patent ...